Cargando…
Advanced glycation end-products, a pathophysiological pathway in the cardiorenal syndrome
The prevalence of heart failure (HF) is increasing. A distinction is made between diastolic HF (preserved left ventricular ejection fraction (LVEF)) and systolic HF (reduced LVEF). Advanced glycation end-products (AGEs) are crystallized proteins that accumulate during ageing, but are particularly in...
Autores principales: | Willemsen, Suzan, Hartog, Jasper W. L., Heiner-Fokkema, M. Rebecca, van Veldhuisen, Dirk J., Voors, Adriaan A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3310987/ https://www.ncbi.nlm.nih.gov/pubmed/21259070 http://dx.doi.org/10.1007/s10741-010-9225-z |
Ejemplares similares
-
Cardiorenal Syndromes: Pathophysiology to Prevention
por: McCullough, Peter A.
Publicado: (2010) -
Advanced Glycation End Products and Psoriasis
por: Maurelli, Martina, et al.
Publicado: (2023) -
An Update on the Pathophysiology and Treatment of Cardiorenal Syndrome
por: Raina, Rupesh, et al.
Publicado: (2020) -
Pathophysiological pathways related to high plasma growth differentiation factor 15 concentrations in patients with heart failure
por: Ceelen, Daan, et al.
Publicado: (2022) -
Dietary Advanced Glycation End Products and Aging
por: Luevano-Contreras, Claudia, et al.
Publicado: (2010)